# Ocracoke Health Center Inc

Health Center, NC
Page: https://astrelis.co/providers/health_center/341014  
This twin: https://astrelis.co/providers/health_center/341014.md  
CMS Certification Number (CCN): 341014  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 3,180. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -68.9%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 4. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 15.3%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $3.5M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** -21.6%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Ocracoke Health Center, Inc., NC

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state (FACLAND tier 1)).

- FY ending 2025-01-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-01-GSAFAC-0000376634
- FY ending 2024-01-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-01-GSAFAC-0000061967
- FY ending 2023-01-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-01-GSAFAC-0000007703

| Line | FY ending 2025-01-31 | FY ending 2024-01-31 | FY ending 2023-01-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 150,148 [derived, p.6] | 617,379 [derived, p.6] | 1,792,002 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 208,794 [derived, p.6] | 214,201 [derived, p.6] | 249,973 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 300,661 [derived, p.6] | 136,112 [derived, p.6] | 400,452 [derived, p.6] |
| other current assets (Statement of financial position) | 168,605 [derived, p.6] | 204,194 [derived, p.6] | 162,310 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 828,208 [extracted, p.6] | 1,171,886 [extracted, p.6] | 2,604,737 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 2,555,449 [derived, p.6] | 2,705,129 [derived, p.6] | 1,583,758 [derived, p.6] |
| other long-term assets (Statement of financial position) | 211,771 [derived, p.6] | 237,998 [derived, p.6] | 263,242 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 3,595,428 [extracted, p.6] | 4,115,013 [extracted, p.6] | 4,451,737 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 410,403 [derived, p.6] | 386,228 [derived, p.6] | 327,396 [derived, p.6] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 43,000 [derived, p.6] |
| current debt and leases (Statement of financial position) | 27,255 [derived, p.6] | 26,231 [derived, p.6] | 25,244 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 437,658 [extracted, p.6] | 412,459 [extracted, p.6] | 395,640 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 373,516 [derived, p.6] | 211,767 [derived, p.6] | 237,998 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 811,174 [extracted, p.6] | 624,226 [extracted, p.6] | 633,638 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 2,784,254 [derived, p.6] | 3,490,787 [derived, p.6] | 3,630,746 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 187,353 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 2,784,254 [extracted, p.6] | 3,490,787 [extracted, p.6] | 3,818,099 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 1,874,026 [derived, p.7] | 1,344,631 [derived, p.7] | 1,210,674 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 952,628 [derived, p.7] | 630,056 [derived, p.7] | 453,367 [derived, p.7] |
| federal grants (Statement of activities) | 1,303,439 [derived, p.7] | 1,906,241 [derived, p.7] | 1,498,819 [derived, p.7] |
| other grants and contracts (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| contributions (Statement of activities) | 126,727 [derived, p.7] | 120,980 [derived, p.7] | 4,824 [derived, p.7] |
| other revenue (Statement of activities) | 90,938 [derived, p.7] | 63,205 [derived, p.7] | 296,590 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 4,347,758 [extracted, p.7] | 4,065,113 [extracted, p.7] | 3,464,274 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 3,625,545 [derived, p.7] | 3,014,545 [derived, p.7] | 1,950,655 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 262,245 [derived, p.7] | 281,865 [derived, p.7] | 236,851 [derived, p.7] |
| purchased and professional services (Statement of activities) | 434,800 [derived, p.7] | 507,934 [derived, p.7] | 387,525 [derived, p.7] |
| occupancy (Statement of activities) | 166,831 [derived, p.7] | 134,501 [derived, p.7] | 102,959 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 163,887 [derived, p.7] | 102,369 [derived, p.7] | 100,226 [derived, p.7] |
| interest (Statement of activities) | 3,899 [derived, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| other expenses (Statement of activities) | 397,084 [derived, p.7] | 372,514 [derived, p.7] | 163,279 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 5,054,291 [extracted, p.7] | 4,413,728 [extracted, p.7] | 2,941,495 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -706,533 [extracted, p.7] | -348,615 [extracted, p.7] | 522,779 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | 187,353 [derived, p.8] |
| CHANGE IN NET ASSETS (Statement of activities) | -706,533 [extracted, p.8] | -348,615 [extracted, p.8] | 710,132 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 3,490,787 [extracted, p.8] | 3,839,402 [extracted, p.8] | 3,107,967 [extracted, p.8] |
| net assets, end (Statement of activities) | 2,784,254 [extracted, p.8] | 3,490,787 [extracted, p.8] | 3,818,099 [extracted, p.8] |

| Ratio | FY ending 2025-01-31 | FY ending 2024-01-31 | FY ending 2023-01-31 |
|---|---:|---:|---:|
| Days cash on hand | 11 days [plausible] | 52 days [plausible] | 230 days [plausible] |
| Current ratio | 1.89x [plausible] | 2.84x [plausible] | 6.58x [plausible] |
| Operating margin | -16.3% [plausible] | -8.6% [plausible] | 15.1% [plausible] |
| Total margin | -16.3% [plausible] | -8.6% [plausible] | 20.5% [plausible] |
| Patient revenue share | 43.1% [plausible] | 33.1% [plausible] | 34.9% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 71.7% [plausible] | 68.3% [plausible] | 66.3% [plausible] |
| Days in patient receivables | 41 days [plausible] | 58 days [plausible] | 75 days [plausible] |
| Debt to net assets | 0.14x [plausible] | 0.07x [plausible] | 0.07x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Ocracoke Health Center, Inc.; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Ocracoke Health Center Inc", https://astrelis.co/providers/health_center/341014, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.